Drugs

Metabolic Complications Associated with HIV Protease Inhibitor Therapy
pp. 2555-2574(20)
Author: Nolan D.

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease
pp. 2575-2594(20)
Author: Spina D.

CNS Involvement in Overactive Bladder: Pathophysiology and Opportunities for Pharmacological Intervention
pp. 2595-2611(17)
Authors: Andersson K-E.; Pehrson R.

Azelnidipine
pp. 2613-2621(9)
Authors: Wellington K.; Scott L.J.

Azelnidipine: A Viewpoint by Yukihito Higashi
pp. 2623-2624(2)
Author: Higashi Y.

Azelnidipine: A Viewpoint by Junichi Minami
pp. 2623-2624(2)
Author: Minami J.

Azelnidipine: A Viewpoint by Hirofumi Tomiyama and Akira Yamashina
pp. 2623-2624(2)
Authors: Tomiyama H.; Yamashina A.

Combined Hepatitis A and B Vaccines: A Review of Their Immunogenicity and Tolerability
pp. 2625-2649(25)
Authors: Murdoch D.L.; Goa K.; Figgitt D.P.

Levosimendan: A Review of its Use in the Management of Acute Decompensated Heart Failure
pp. 2651-2671(21)
Authors: Innes C.A.; Wagstaff A.J.

Vardenafil: A Review of its Use in Erectile Dysfunction
pp. 2673-2703(31)
Authors: Keating G.M.; Scott L.J.